313 related articles for article (PubMed ID: 2329722)
1. [Analysis of cross-linked fibrin and fibrinogen degradation products with SDS-PAGE and immunoblot].
Okumura N; Kagiya H; Kumagai T; Kameko M; Tozuka M; Saito H; Katsuyama T; Kanai M
Rinsho Byori; 1990 Feb; 38(2):201-7. PubMed ID: 2329722
[TBL] [Abstract][Full Text] [Related]
2. [Differentiation of fibrinolysis and fibrinogenolysis by analysis of FDP fragments].
Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Nakahata T; Saitoh H
Rinsho Byori; 1992 Jul; 40(7):789-94. PubMed ID: 1507499
[TBL] [Abstract][Full Text] [Related]
3. [Serum FDP assay with latex photometric immunoassay and its analysis by immunoblotting].
Okumura N; Kagiya H; Saito H; Katsuyama T; Kanai M
Rinsho Byori; 1991 Jan; 39(1):76-82. PubMed ID: 2008047
[TBL] [Abstract][Full Text] [Related]
4. [Studies on the fragments of FDP in 3 patients with DIC associated with acute promyelocytic leukemia].
Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Nakahata T; Saitoh H
Rinsho Byori; 1993 Jun; 41(6):719-25. PubMed ID: 8361040
[TBL] [Abstract][Full Text] [Related]
5. [Studies on the fragments of FDP in 4 patients with DIC].
Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Nakahata T; Saitoh H
Rinsho Byori; 1992 Oct; 40(10):1089-95. PubMed ID: 1307614
[TBL] [Abstract][Full Text] [Related]
6. [Studies on the fragments of FDP in 3 non-DIC patients with increased FDP levels in the sera].
Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Shinoda T; Nakahata T; Saitoh H
Rinsho Byori; 1993 Feb; 41(2):220-6. PubMed ID: 8361025
[TBL] [Abstract][Full Text] [Related]
7. [Clinical significance of a new fibrinogen/fibrin degradation products(FDP) test using plasma samples for the diagnosis of fibrinogenolysis and fibrinolysis].
Imoto K; Yasumuro Y; Taki M; Suzuki N; Tanabe H; Ichikawa Y
Rinsho Byori; 2001 Mar; 49(3):283-9. PubMed ID: 11307330
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of antibody reactivity for FDP D-dimer fragments by Western blotting].
Wakabayashi S; Ishikawa S; Hirota-Kawadobora M; Fujihara N; Kamijyo Y; Yamauchi K; Terasawa F; Okumura N; Katsuyama T
Rinsho Byori; 2008 Jun; 56(6):449-54. PubMed ID: 18646629
[TBL] [Abstract][Full Text] [Related]
9. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A.
Pfitzner SA; Dempfle CE; Matsuda M; Heene DL
Thromb Haemost; 1997 Sep; 78(3):1069-78. PubMed ID: 9308756
[TBL] [Abstract][Full Text] [Related]
10. [Clinical evaluation of a test for plasma fibrin/fibrinogen degradation products (FDP) based on monoclonal anti-FDP antibody technology: an application for the scoring system of the disseminated intravascular coagulation (DIC) diagnostic criteria].
Ito K; Wada H; Abe Y; Tomatsu H; Nishioka J; Nobori T
Rinsho Byori; 2003 Apr; 51(4):295-9. PubMed ID: 12747249
[TBL] [Abstract][Full Text] [Related]
11. [Studies on the blood coagulation factor XIII in patients with increased levels of FDP D-dimer].
Okumura N; Matsuzawa A; Terasawa F; Kameko M; Sasaki Y; Nakagoshi R; Ishikawa S; Hashikura Y; Matsunami H; Kawasaki S
Rinsho Byori; 1995 Mar; 43(3):269-74. PubMed ID: 7745833
[TBL] [Abstract][Full Text] [Related]
12. A quantitative enzyme immunoassay for primary fibrinogenolysis products in plasma.
Koppert PW; Kuipers W; Hoegee-de Nobel B; Brommer EJ; Koopman J; Nieuwenhuizen W
Thromb Haemost; 1987 Feb; 57(1):25-8. PubMed ID: 2438796
[TBL] [Abstract][Full Text] [Related]
13. Determination of plasma soluble fibrin using a new ELISA method in patients with disseminated intravascular coagulation.
Okajima K; Uchiba M; Murakami K; Okabe H; Takatsuki K
Am J Hematol; 1996 Mar; 51(3):186-91. PubMed ID: 8619398
[TBL] [Abstract][Full Text] [Related]
14. Fibrin and fibrinogen proteolysis products: comparison between gel filtration and SDS polyacrylamide electrophoresis analysis.
Alkjaersig N; Davies A; Fletcher A
Thromb Haemost; 1977 Aug; 38(2):524-5. PubMed ID: 145666
[TBL] [Abstract][Full Text] [Related]
15. Measurement of plasma fibrin D-dimer levels with the use of a monoclonal antibody coupled to latex beads.
Greenberg CS; Devine DV; McCrae KM
Am J Clin Pathol; 1987 Jan; 87(1):94-100. PubMed ID: 3541576
[TBL] [Abstract][Full Text] [Related]
16. Distinct reactivity of the commercially available monoclonal antibodies of D-dimer and plasma FDP testing to the molecular variants of fibrin degradation products.
Madoiwa S; Kitajima I; Ohmori T; Sakata Y; Mimuro J
Thromb Res; 2013 Oct; 132(4):457-64. PubMed ID: 24011388
[TBL] [Abstract][Full Text] [Related]
17. Unreliability in the estimation of the molecular weight of fibrinogen degradation products (FDPs) by polyacrylamide/sodium dodecyl sulphate electrophoresis (SDS/PAGE).
Arocha-PiƱango CL; Perales J; Carvajal Z
Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(5):737-41. PubMed ID: 2416650
[TBL] [Abstract][Full Text] [Related]
18. [A proposed method for the laboratory diagnosis of disseminated intravascular coagulation in liver cirrhosis].
Cristani A; Cioni G; Mussini C; Pentore R; Zagni G; Ventura E
Recenti Prog Med; 1990 May; 81(5):322-4. PubMed ID: 2377810
[TBL] [Abstract][Full Text] [Related]
19. Biological behavior of higher molecular weight products of fibrinolysis.
Chang ML; Bang NU
J Lab Clin Med; 1977 Jul; 90(1):216-26. PubMed ID: 874368
[TBL] [Abstract][Full Text] [Related]
20. Fibrin degradation products, fibrin monomer and soluble fibrin in disseminated intravascular coagulation.
Horan JT; Francis CW
Semin Thromb Hemost; 2001 Dec; 27(6):657-66. PubMed ID: 11740689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]